Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole

Southeast Asian J Trop Med Public Health. 2005 Mar;36(2):442-4.

Abstract

The stools of 697 cases were examined by agar plate technique at Tambon Makam Luang, Sun Pa Tong district, Chiang Mai; there were Strongyloides stercoralis 15.9%,Opisthorchis viverrini 5.1%, intestinal fluke 0.1%. Treatment with ivermectin 78 cases and albendazole 33 cases of strongyloidiasis gave cure rates at 98.7% and 78.7%, respectively. Alkaline phosphatase in some patients were increased at mild level after treatment. Side effects in ivermectin group were anorexia, nausia, diarrhea, diffuse itching and drowsiness; and in albendazole group were nausia and diarrhea. The efficacy of single dose and mild side effects suggest ivermectin as drug of choice for strongyloidiasis treatment.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albendazole / adverse effects
  • Albendazole / therapeutic use*
  • Animals
  • Anthelmintics / adverse effects
  • Anthelmintics / therapeutic use*
  • Feces / parasitology
  • Female
  • Humans
  • Ivermectin / adverse effects
  • Ivermectin / therapeutic use*
  • Liver Function Tests
  • Male
  • Prevalence
  • Sex Distribution
  • Strongyloides / drug effects*
  • Strongyloides / isolation & purification
  • Strongyloidiasis / drug therapy*
  • Strongyloidiasis / epidemiology
  • Thailand / epidemiology

Substances

  • Anthelmintics
  • Ivermectin
  • Albendazole